Glaukos (GKOS) EPS (Diluted) Growth (3y) (2017 - 2026)
Glaukos (GKOS) EPS (Diluted) Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -12.16% |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 19.81% |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 50.83% |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -6.12% |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 33.46% |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 11.48% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1,810.75% |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 18.07% |
| 10 | Glaukos | 11.08 Bn | 10.96 Bn | 151.59 Mn | 22.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.76% |
| Mar 31, 2026 | 22.15% |
| Dec 31, 2025 | -35.53% |
| Sep 30, 2025 | 21.26% |
| Jun 30, 2025 | 29.04% |
| Mar 31, 2025 | -70.42% |
| Dec 31, 2024 | 45.37% |
| Sep 30, 2024 | -71.94% |
| Jun 30, 2024 | -38.21% |
| Mar 31, 2024 | -31.76% |
| Dec 31, 2023 | 3.35% |
| Sep 30, 2023 | -21.09% |
| Jun 30, 2023 | 11.17% |
| Mar 31, 2023 | 18.05% |
| Dec 31, 2022 | -41.30% |
| Sep 30, 2022 | -16.07% |
| Jun 30, 2022 | -77.14% |
| Mar 31, 2022 | 70.20% |
| Dec 31, 2021 | -207.22% |
| Sep 30, 2021 | 38.87% |